The Epidemiology of Acute Respiratory Distress Among Children, A Retrospective Cross-Sectional Study

The Epidemiology of Acute Respiratory Distress Among Children, A Retrospective Cross-Sectional Study From Iran

l Respiratory distress is still a major concern in pediatric medicine. l In this study we evaluated the symptoms and causes of respiratory distress among children in a tertiary hospital.

l We found that tachypnea is the most common symptom and asthma is the most common cause of respiratory distress in children.

Study Overview

• Status: Completed
• Conditions: Acute Respiratory Distress
• Intervention / Treatment: Other: descriptive study

• Study Type: Observational
• Enrollment (Actual): 154

Contacts and Locations

Study Locations

• Iran, Islamic Republic of
  • Tehran, Iran, Islamic Republic of, 1766884349
    • Mahdis Bayat

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

From a total of 186 patients who visited the emergency room of Mofid Children's Hospital during the period of the study, 154 included in the study

Description

Inclusion Criteria:

• patients older than one month
• signs or symptoms of respiratory distress, including tachypnea, bradypnea, cyanosis, respiratory muscle retraction, nasal flaring, tachycardia, and bradycardia

Exclusion Criteria:

• Patients older than 18 years old
• apnea
• known cardiac diseases

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
The most common symptom	six months
The most common cause of respiratory distress	six months

Collaborators and Investigators

• Sponsor: Mofid Children Hospital
• Collaborators: Dr Fatemeh Shojaeian, Dr seyed mohamadsadegh mousavi-kiasary, Dr Samira Sayyah

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2018
• Primary Completion (Actual): April 30, 2019
• Study Completion (Actual): December 30, 2019

Study Registration Dates

• First Submitted: August 26, 2024
• First Submitted That Met QC Criteria: August 27, 2024
• First Posted (Actual): August 29, 2024

Study Record Updates

• Last Update Posted (Actual): August 29, 2024
• Last Update Submitted That Met QC Criteria: August 27, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: MofidCH

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No